<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Market News &#38; Stocks to Watch from StraightStocks &#187; Sinobiomed Inc.</title>
	<atom:link href="http://www.straightstocks.com/tag/sinobiomed-inc/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.straightstocks.com</link>
	<description>Leading Stock Market News, Opinions and Commentary</description>
	<lastBuildDate>Tue, 24 Nov 2009 10:00:29 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Majic Wheels Corp. (MJWL.OB) is “One to Watch”</title>
		<link>http://www.straightstocks.com/market-commentary/majic-wheels-corp-mjwl-ob-is-%e2%80%9cone-to-watch%e2%80%9d/</link>
		<comments>http://www.straightstocks.com/market-commentary/majic-wheels-corp-mjwl-ob-is-%e2%80%9cone-to-watch%e2%80%9d/#comments</comments>
		<pubDate>Thu, 02 Jul 2009 17:15:47 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Asher Zwebner;]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Britanica.com]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Cfo]]></category>
		<category><![CDATA[Chief Financial Officer]]></category>
		<category><![CDATA[classic remote control car]]></category>
		<category><![CDATA[climbing device]]></category>
		<category><![CDATA[climbing device technology]]></category>
		<category><![CDATA[CPA;]]></category>
		<category><![CDATA[device technology;]]></category>
		<category><![CDATA[educational software]]></category>
		<category><![CDATA[Ernst & Young International]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[internet distributors]]></category>
		<category><![CDATA[israel]]></category>
		<category><![CDATA[leading player]]></category>
		<category><![CDATA[Majic Wheels Corp.]]></category>
		<category><![CDATA[PCMT Corporation]]></category>
		<category><![CDATA[President and CFO]]></category>
		<category><![CDATA[senior manager]]></category>
		<category><![CDATA[senior manager at the Israeli branch]]></category>
		<category><![CDATA[Sinobiomed Inc.]]></category>
		<category><![CDATA[SMC Ventures]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[toy car world]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=15667</guid>
		<description><![CDATA[Majic Wheels Corp. is focused on bringing innovation to the industry of radio-controlled toy cars by introducing its groundbreaking, patented climbing device technology. The company aims to become a leading player in the climbing device radio-controlled toy car world, offering models in multiple aesthetically pleasing designs and a variety of colors. With the U.S. toy [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/majic-wheels-corp-mjwl-ob-is-%e2%80%9cone-to-watch%e2%80%9d/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sinobiomed Inc. (SOBM.OB): Chinese Wonder Drug-Maker?</title>
		<link>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/sinobiomed-inc-sobmob-chinese-wonder-drug-maker/</link>
		<comments>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/sinobiomed-inc-sobmob-chinese-wonder-drug-maker/#comments</comments>
		<pubDate>Sat, 06 Sep 2008 02:17:20 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Accelera Ventures]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cents]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[hepatitis]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Malaria]]></category>
		<category><![CDATA[Pharmaceutical Industry]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[shanghai]]></category>
		<category><![CDATA[Sinobiomed Inc.]]></category>
		<category><![CDATA[skin care products]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vaccines]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=12185</guid>
		<description><![CDATA[	Sinobiomed (SOBM) is a Chinese developer of genetically engineered recombinant protein drugs and vaccines. The company&#8217;s drugs treat diseases and ailments such as malaria, hepatitis, surgical bleeding, cancer, rheumatoid arthritis, diabetic ulcers and burns, and blood cell regeneration.  Sinobiomed currently has 10 products: three on the market, four in clinical trials and three in [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/sinobiomed-inc-sobmob-chinese-wonder-drug-maker/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HotStix Stock of the Week &#8211; Sinobiomed Inc. (SOBM.OB)</title>
		<link>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/hotstix-stock-of-the-week-sinobiomed-inc-sobmob/</link>
		<comments>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/hotstix-stock-of-the-week-sinobiomed-inc-sobmob/#comments</comments>
		<pubDate>Tue, 26 Aug 2008 17:19:34 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[liver disease]]></category>
		<category><![CDATA[Malaria]]></category>
		<category><![CDATA[pancreatitis]]></category>
		<category><![CDATA[pharmaceutical distribution]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Sinobiomed Inc.]]></category>
		<category><![CDATA[stroke]]></category>
		<category><![CDATA[Suzhou Boai Medical Development Company]]></category>
		<category><![CDATA[thrombosis]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Week - Sinobiomed Inc.]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=11971</guid>
		<description><![CDATA[Sinobiomed Inc. (SOBM.OB) is a leading Chinese developer of genetically engineered recombinant protein drugs and vaccines. Sinobiomed employs a patented low-cost, high yield production process to enhance bioactivity and guarantee the highest levels of purity.
Sinobiomed currently has 10 products approved or in development: three on the market, four in clinical trials, and three in R&#38;D. [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/hotstix-stock-of-the-week-sinobiomed-inc-sobmob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vaccine Trials, Uses, Progress for Sinobiomed, Inc. (SOBM.OB)</title>
		<link>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/vaccine-trials-uses-progress-for-sinobiomed-inc-sobmob/</link>
		<comments>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/vaccine-trials-uses-progress-for-sinobiomed-inc-sobmob/#comments</comments>
		<pubDate>Thu, 21 Aug 2008 12:10:46 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Bangkok]]></category>
		<category><![CDATA[genetic engineering]]></category>
		<category><![CDATA[Mahidol University in Bangkok]]></category>
		<category><![CDATA[Malaria]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Sinobiomed Inc.]]></category>
		<category><![CDATA[Thailand]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=11869</guid>
		<description><![CDATA[Sinobiomed’s (OTCBB: SOBM) recombinant Batroxobin (rBAT) is in its Phase IIb trials for 328 patients. Results are expected before year’s end. A company news release says international interest from government and organizations would grow significantly if the product proceeds to Phase III clinical trials.
“[We have] already received indications of interest from global pharmaceutical companies for [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/vaccine-trials-uses-progress-for-sinobiomed-inc-sobmob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
